These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1985866)
1. Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread. Theodorescu D; Cornil I; Sheehan C; Man S; Kerbel RS Int J Cancer; 1991 Jan; 47(1):118-23. PubMed ID: 1985866 [TBL] [Abstract][Full Text] [Related]
2. Clonal selection within metastatic SP1 mouse mammary tumors is independent of metastatic potential. Samiei M; Waghorne CG Int J Cancer; 1991 Mar; 47(5):771-5. PubMed ID: 2004857 [TBL] [Abstract][Full Text] [Related]
3. Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions. Rak JW; Kerbel RS In Vitro Cell Dev Biol Anim; 1993 Sep; 29A(9):742-8. PubMed ID: 8407718 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetic heterogeneity of genetically marked and metastatically competent "dominant" tumor cell clones. Bell C; Frost P; Kerbel RS Cancer Genet Cytogenet; 1991 Jul; 54(2):153-61. PubMed ID: 1884347 [TBL] [Abstract][Full Text] [Related]
5. Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Waghorne C; Thomas M; Lagarde A; Kerbel RS; Breitman ML Cancer Res; 1988 Nov; 48(21):6109-14. PubMed ID: 3167857 [TBL] [Abstract][Full Text] [Related]
7. Clonal changes in tumours during growth and progression evaluated by southern gel analysis of random integrations of foreign DNA. Kerbel RS; Waghorne C; Korczak B; Breitman ML Ciba Found Symp; 1988; 141():123-48. PubMed ID: 2855413 [TBL] [Abstract][Full Text] [Related]
8. Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo. Korczak B; Robson IB; Lamarche C; Bernstein A; Kerbel RS Mol Cell Biol; 1988 Aug; 8(8):3143-9. PubMed ID: 3211140 [TBL] [Abstract][Full Text] [Related]
9. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Kerbel RS; Waghorne C; Korczak B; Lagarde A; Breitman ML Cancer Surv; 1988; 7(4):597-629. PubMed ID: 3072068 [TBL] [Abstract][Full Text] [Related]
10. Karyotypic evolution of a murine mammary adenocarcinoma in vitro and during progression from primary to metastatic growth in vivo. Elliott BE; Xu W; Mudrik K; Marshall J; Vekemans M; Holden JJ Genes Chromosomes Cancer; 1992 Jun; 4(4):281-9. PubMed ID: 1377934 [TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells. Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487 [TBL] [Abstract][Full Text] [Related]
12. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing. Man S; Munoz R; Kerbel RS Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863 [TBL] [Abstract][Full Text] [Related]
13. Metastasizing potentials of mouse mammary tumors and their metastases. Vaage J Int J Cancer; 1988 Jun; 41(6):855-8. PubMed ID: 3372061 [TBL] [Abstract][Full Text] [Related]
14. The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal-cell carcinoma grown in nude mice. Staroselsky AN; Radinsky R; Fidler IJ; Pathak S; Chernajovsky Y; Frost P Int J Cancer; 1992 Apr; 51(1):130-8. PubMed ID: 1563832 [TBL] [Abstract][Full Text] [Related]
15. Progression toward metastatic phenotype with loss of growth-inhibiting tumor-cell/cell interactions in vivo. Takeda Y; Sayama K; Saegusa Y; Matsuzawa A Int J Cancer; 1995 Sep; 62(5):579-84. PubMed ID: 7665229 [TBL] [Abstract][Full Text] [Related]
16. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969 [TBL] [Abstract][Full Text] [Related]
17. Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Kerbel RS; Waghorne C; Man MS; Elliott B; Breitman ML Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1263-7. PubMed ID: 3469668 [TBL] [Abstract][Full Text] [Related]
18. Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression. Radinsky R; Culp LA Int J Cancer; 1991 Apr; 48(1):148-59. PubMed ID: 2019453 [TBL] [Abstract][Full Text] [Related]
19. Rodent model of systemic mammary tumor disease by surgical removal of the spontaneously metastasizing SMT2A mammary carcinoma: inhibitory effect of the stable prostacyclin analogue cicaprost on occult metastasis. Schirner M; Schneider MR Int J Cancer; 1995 Jul; 62(2):205-9. PubMed ID: 7622297 [TBL] [Abstract][Full Text] [Related]
20. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma. Alonso DF; Farías EF; Urtreger A; Ladeda V; Vidal MC; Bal De Kier Joffé E J Surg Oncol; 1996 Aug; 62(4):288-97. PubMed ID: 8691844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]